tiprankstipranks
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
SPRY
ARS Pharmaceuticals
RESEARCH TOOLSreports
Want to see SPRY full AI Analyst Report?

ARS Pharmaceuticals (SPRY) Ratios

589 Followers

ARS Pharmaceuticals Ratios

SPRY's free cash flow for Q2 2026 was $0.62. For the 2026 fiscal year, SPRY's free cash flow was decreased by $ and operating cash flow was $-1.78. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.48 7.28 14.26 96.85 51.01
Quick Ratio
 3.28 7.06 14.04 96.85 51.01
Cash Ratio
 0.13 1.06 2.17 29.68 38.67
Solvency Ratio
 -0.89 -0.80 0.09 -22.36 -4.02
Operating Cash Flow Ratio
 -3.23 -4.36 0.58 -24.79 -7.36
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 -250.07 0.00
Net Current Asset Value
$ -25.47M$ 71.50M$ 239.94M$ 229.13M$ 269.15M
Leverage Ratios
Debt-to-Assets Ratio
 0.69 0.29 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 13.72 0.84 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.93 0.46 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.93 0.46 0.00 0.00 0.00
Financial Leverage Ratio
 19.94 2.87 1.37 1.01 1.03
Debt Service Coverage Ratio
 -42.06 -64.38 0.00 -284.59 0.00
Interest Coverage Ratio
 -43.96 -69.05 0.00 0.00 0.00
Debt to Market Cap
 0.36 0.08 0.00 <0.01 0.00
Interest Debt Per Share
 1.78 1.00 <0.01 <0.01 0.01
Net Debt to EBITDA
 -0.79 -0.33 -6.07 1.05 5.97
Profitability Margins
Gross Profit Margin
73.89%75.77%76.94%100.00%100.00%
EBIT Margin
-180.11%-200.26%9.29%-225066.67%-2698.78%
EBITDA Margin
-177.04%-198.64%9.38%-224823.33%-2674.54%
Operating Profit Margin
-184.96%-212.92%-3.46%-225066.67%-2698.78%
Pretax Profit Margin
-184.31%-203.35%9.29%-181216.67%-2635.41%
Net Profit Margin
-184.24%-203.25%8.97%-181216.67%-2635.41%
Continuous Operations Profit Margin
-184.24%-203.25%8.97%-181216.67%-2635.41%
Net Income Per EBT
99.96%99.95%96.52%100.00%100.00%
EBT Per EBIT
99.65%95.50%-268.76%80.52%97.65%
Return on Assets (ROA)
-86.35%-52.28%2.28%-23.31%-12.32%
Return on Equity (ROE)
-256.67%-149.92%3.11%-23.56%-12.71%
Return on Capital Employed (ROCE)
-114.65%-62.20%-0.94%-29.26%-12.87%
Return on Invested Capital (ROIC)
-114.61%-62.17%-0.91%-29.23%-12.86%
Return on Tangible Assets
-91.44%-54.69%2.33%-23.31%-12.32%
Earnings Yield
-45.57%-14.92%0.78%-10.42%-10.18%
Efficiency Ratios
Receivables Turnover
 2.50 3.20 9.73 0.04 0.00
Payables Turnover
 0.51 3.57 2.08 0.00 0.00
Inventory Turnover
 2.61 2.44 3.94 0.00 0.00
Fixed Asset Turnover
 56.08 34.19 83.63 0.04 1.70
Asset Turnover
 0.47 0.26 0.25 <0.01 <0.01
Working Capital Turnover Ratio
 0.68 0.30 0.33 <0.01 <0.01
Cash Conversion Cycle
 -428.26 161.36 -45.19 9.67K 0.00
Days of Sales Outstanding
 146.21 114.11 37.51 9.67K 0.00
Days of Inventory Outstanding
 139.77 149.57 92.54 0.00 0.00
Days of Payables Outstanding
 714.24 102.32 175.25 0.00 0.00
Operating Cycle
 285.98 263.68 130.05 9.67K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.98 -1.73 0.14 -0.62 -1.00
Free Cash Flow Per Share
 -1.98 -1.74 0.13 -0.62 -1.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 0.96 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -996.98 -504.03 24.06 -338.66 -201.40
Capital Expenditure Coverage Ratio
 -996.98 -504.03 24.06 -338.66 -201.40
Operating Cash Flow Coverage Ratio
 -1.14 -1.77 322.57 -216.30 -83.32
Operating Cash Flow to Sales Ratio
 -1.68 -2.03 0.15 -1.98K -30.45
Free Cash Flow Yield
-41.59%-14.91%1.27%-11.39%-11.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.18 -6.70 127.88 -9.60 -9.83
Price-to-Sales (P/S) Ratio
 4.04 13.63 11.47 17.39K 258.99
Price-to-Book (P/B) Ratio
 37.78 10.05 3.98 2.26 1.25
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.40 -6.71 78.76 -8.78 -8.46
Price-to-Operating Cash Flow Ratio
 -2.41 -6.72 75.49 -8.80 -8.50
Price-to-Earnings Growth (PEG) Ratio
 0.02 <0.01 -1.12 0.28 -0.40
Price-to-Fair Value
 37.78 10.05 3.98 2.26 1.25
Enterprise Value Multiple
 -3.07 -7.19 116.19 -6.69 -3.72
Enterprise Value
 636.12M 1.20B 971.91M 451.08M 130.79M
EV to EBITDA
 -3.07 -7.19 116.19 -6.69 -3.72
EV to Sales
 5.44 14.28 10.90 15.04K 99.38
EV to Free Cash Flow
 -3.24 -7.03 74.85 -7.59 -3.25
EV to Operating Cash Flow
 -3.24 -7.04 71.74 -7.61 -3.26
Tangible Book Value Per Share
 -0.01 1.01 2.57 2.42 6.83
Shareholders’ Equity Per Share
 0.13 1.16 2.65 2.42 6.83
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 0.03 0.00 0.00
Revenue Per Share
 1.18 0.86 0.92 <0.01 0.03
Net Income Per Share
 -2.17 -1.74 0.08 -0.57 -0.87
Tax Burden
 1.00 1.00 0.97 1.00 1.00
Interest Burden
 1.02 1.02 1.00 0.81 0.98
Research & Development to Revenue
 0.13 0.16 0.22 675.53 13.96
SG&A to Revenue
 2.43 2.73 0.00 1.58K 14.02
Stock-Based Compensation to Revenue
 0.27 0.26 0.16 307.83 4.44
Income Quality
 0.91 1.00 1.69 1.09 1.16
Currency in USD